Store
30-Country IVD Market Atlas, 2026 – July Update
Publication Date: July 20, 2026
Tags: AMEA, APAC, Asia, Blood Screening, China, Coagulation, COVID-19, Critical Care, Diagnostic Instruments, Europe, Genetic Diseases, Global Market, Glucose, Hematology, Histology and Cytology, Immunoassay, In Vitro Diagnostics (IVD), India, Infectious Diseases, IVD, Japan, Latin America, Middle East, Molecular Diagnostics, North America, Oncology and Cancer, Other Asia Pacific, Point of Care, Point-of-Care (POC) Diagnostics, Point-of-Care (POC) Testing, Respiratory Diseases
Pages: 158
SKU: 26-020KA
Kalorama Information’s 30-Country IVD Market Atlas, 2026 provides a comprehensive analysis of the in vitro diagnostic (IVD) markets across 30 key countries, including the United States, China, Germany, United Kingdom, Saudi Arabia, India, Japan, France, Vietnam, and Turkey, among others. This in-depth report delivers detailed market sizing and forecasts spanning five years, tracking 18 IVD segments across all 30 markets to provide timely insights into the evolving global IVD landscape.
Comprehensive Segment Coverage
Leveraging over two decades of market research expertise, Kalorama Information presents a country-level approach, offering granular estimates for critical IVD segments, including:
- Blood Bank Screening – Immunoassays
- General Chemistry and Critical Care (Core Laboratory)
- Hematology and Coagulation PT/INR
- Histology
- Immunoassays – Microbiology
- Immunoassays – Non-Microbiology
- Microbiology – ID/AST
- Molecular Bloodstream/HAI
- Molecular HIV & Hepatitis
- Molecular Respiratory
- Molecular – Other
- POC Critical Care
- POC Fecal Occult Blood Testing
- POC Glucose
- POC Infectious Disease (All)
- POC Pregnancy & Fertility
- Other POC
- Other IVD
Market Drivers and Trends
The IVD market is entering a period of more stable expansion, with growth shifting away from routine test volume toward higher-value technologies that offer improved accuracy, faster results, and stronger clinical utility. The report examines the key drivers behind this transition. The report also captures market-shaping developments and country-level dynamics—from stronger 2025 performance in markets like Poland, the Netherlands, Switzerland, and Romania, to the ongoing challenges facing Russia amid geopolitical disruption and sanctions.
New Cross-Country Appendix
New to this edition, an appendix presents Kalorama Information’s market estimates in a segment-by-segment structure, offering a cross-country view of each of the 18 IVD segments covered in the report. Each tab corresponds to one segment, with rows representing the 30 markets and columns showing 2025 estimated revenue, 2030 projected revenue, and the 2025–2030 CAGR. A total row aggregates all 30 markets and derives the implied segment-level CAGR across the full country set. The underlying data is identical to that found in the individual country tables, recontextualized for readers comparing segment performance across geographies rather than across market chapters.
A Single, Authoritative Resource
Unlike fragmented country-specific reports, Kalorama’s 30-Country IVD Market Atlas, 2026 consolidates these insights into a single, authoritative resource, aligning with its mission to deliver comprehensive and actionable market intelligence. The report will be published twice in 2026, with the first edition released in July and a second following in Q4; buyers receive access to both editions with purchase, ensuring they remain informed with the most up-to-date data for strategic decision-making in the dynamic global IVD market.
Chapter One: Worldwide IVD Market
About Kalorama Information
IVD Market Demand and Growth
Scope and Methodology
Market Segmentation
Blood Bank Screening – Immunoassays
Coagulation – PT/INR
Critical Care (Core Laboratory)
General Chemistry
Hematology
Histology
Immunoassays – Microbiology
Immunoassays – Non-Microbiology
Molecular – Bloodstream/HAI
Molecular – HIV and Hepatitis
Microbiology – ID/AST
Molecular – Respiratory
Point-of-Care (POC) Testing
- POC Critical Care
- POC Fecal Occult
- POC Glucose (All)
- POC Infectious Disease (All)
- POC Pregnancy and Fertility
Country Atlas Scope
- Table 1-1: Key Interest Countries (30-Country Atlas) for IVD Markets, 2025
Leading Country Revenues
- Table 1-2: Global IVD Market by Leading Countries, Estimated 2025-2030 (US$ million)
- Figure 1-1: Leading Global IVD Market #1-#15 Comparison, Estimated 2025-2030 (US$ million)
- Figure 1-2: Second-Tier Leading Global IVD Market #16-#30 Comparison, Estimated 2025-2030 (US$ million)
Chapter Two: United States
United States IVD Market Overview
- Table 2-1: United States IVD Market by Segment, Estimated 2025-2030 (US$ million)
- Figure 2-1: United States IVD Market by Segment, Estimated 2025-2030 (US$ million)
News
Chapter Three: Germany
Germany IVD Market Overview
- Table 3-1: Germany IVD Market by Segment, Estimated 2025-2030 (US$ million)
- Figure 3-1: Germany IVD Market by Segment, Estimated 2025-2030 (US$ million)
News
Chapter Four: China
China IVD Market Overview
- Table 4-1: China IVD Market by Segment, Estimated 2025-2030 (US$ million)
- Figure 4-1: China IVD Market by Segment, Estimated 2025-2030 (US$ million)
News
Chapter Five: Japan
Japan IVD Market Overview
- Table 5-1: Japan IVD Market by Segment, Estimated 2025-2030 (US$ million)
- Figure 5-1: Japan IVD Market by Segment, Estimated 2025-2030 (US$ million)
News
Chapter Six: France
France IVD Market Overview
- Table 6-1: France IVD Market by Segment, Estimated 2025-2030 (US$ million)
- Figure 6-1: France IVD Market by Segment, Estimated 2025-2030 (US$ million)
News
Chapter Seven: United Kingdom
United Kingdom IVD Market Overview
- Table 7-1: United Kingdom IVD Market by Segment, Estimated 2025-2030 (US$ million)
- Figure 7-1: United Kingdom IVD Market by Segment, Estimated 2025-2030 (US$ million)
News
Chapter Eight: Italy
Italy IVD Market Overview
- Table 8-1: Italy IVD Market by Segment, Estimated 2025-2030 (US$ million)
- Figure 8-1: Italy IVD Market by Segment, Estimated 2025-2030 (US$ million)
News
Chapter Nine: Canada
Canada IVD Market Overview
- Table 9-1: Canada IVD Market by Segment, Estimated 2025-2030 (US$ million)
- Figure 9-1: Canada IVD Market by Segment, Estimated 2025-2030 (US$ million)
News
Chapter Ten: Spain
Spain IVD Market Overview
- Table 10-1: Spain IVD Market by Segment, Estimated 2025-2030 (US$ million)
- Figure 10-1: Spain IVD Market by Segment, Estimated 2025-2030 (US$ million)
Chapter Eleven: Australia
Australia IVD Market Overview
- Table 11-1: Australia IVD Market by Segment, Estimated 2025-2030 (US$ million)
- Figure 11-1: Australia IVD Market by Segment, Estimated 2025-2030 (US$ million)
Chapter Twelve: Brazil
Brazil IVD Market Overview
- Table 12-1: Brazil IVD Market by Segment, Estimated 2025-2030 (US$ million)
- Figure 12-1: Brazil IVD Market by Segment, Estimated 2025-2030 (US$ million)
News
Chapter Thirteen: India
India IVD Market Overview
- Table 13-1: India IVD Market by Segment, Estimated 2025-2030 (US$ million)
- Figure 13-1: India IVD Market by Segment, Estimated 2025-2030 (US$ million)
News
Chapter Fourteen: Russia
Russia IVD Market Overview
- Table 14-1: Russia IVD Market by Segment, Estimated 2025-2030 (US$ million)
- Figure 14-1: Russia IVD Market by Segment, Estimated 2025-2030 (US$ million)
Chapter Fifteen: The Netherlands
The Netherlands IVD Market Overview
- Table 15-1: The Netherlands IVD Market by Segment, Estimated 2025-2030 (US$ million)
- Figure 15-1: The Netherlands IVD Market by Segment, Estimated 2025-2030 (US$ million)
News
Chapter Sixteen: Switzerland
Switzerland IVD Market Overview
- Table 16-1: Switzerland IVD Market by Segment, Estimated 2025-2030 (US$ million)
- Figure 16-1: Switzerland IVD Market by Segment, Estimated 2025-2030 (US$ million)
Chapter Seventeen: Turkey
Turkey IVD Market Overview
- Table 17-1: Turkey IVD Market by Segment, Estimated 2025-2030 (US$ million)
- Figure 17-1: Turkey IVD Market by Segment, Estimated 2025-2030 (US$ million)
Chapter Eighteen: Poland
Poland IVD Market Overview
- Table 18-1: Poland IVD Market by Segment, Estimated 2025-2030 (US$ million)
- Figure 18-1: Poland IVD Market by Segment, Estimated 2025-2030 (US$ million)
News
Chapter Nineteen: Mexico
Mexico IVD Market Overview
- Table 19-1: Mexico IVD Market by Segment, Estimated 2025-2030 (US$ million)
- Figure 19-1: Mexico IVD Market by Segment, Estimated 2025-2030 (US$ million)
Chapter Twenty: Sweden
Sweden IVD Market Overview
- Table 20-1: Sweden IVD Market by Segment, Estimated 2025-2030 (US$ million)
- Figure 20-1: Sweden IVD Market by Segment, Estimated 2025-2030 (US$ million)
News
Chapter Twenty-One: Belgium
Belgium IVD Market Overview
- Table 21-1: Belgium IVD Market by Segment, Estimated 2025-2030 (US$ million)
- Figure 21-1: Belgium IVD Market by Segment, Estimated 2025-2030 (US$ million)
Chapter Twenty-Two: Austria
Austria IVD Market Overview
- Table 22-1: Austria IVD Market by Segment, Estimated 2025-2030 (US$ million)
- Figure 22-1: Austria IVD Market by Segment, Estimated 2025-2030 (US$ million)
Chapter Twenty-Three: Saudi Arabia
Saudi Arabia IVD Market Overview
- Table 23-1: Saudi Arabia IVD Market by Segment, Estimated 2025-2030 (US$ million)
- Figure 23-1: Saudi Arabia IVD Market by Segment, Estimated 2025-2030 (US$ million)
Chapter Twenty-Four: South Korea
South Korea IVD Market Overview
- Table 24-1: South Korea IVD Market by Segment, Estimated 2025-2030 (US$ million)
- Figure 24-1: South Korea IVD Market by Segment, Estimated 2025-2030 (US$ million)
News
Chapter Twenty-Five: Egypt
Egypt IVD Market Overview
- Table 25-1: Egypt IVD Market by Segment, Estimated 2025-2030 (US$ million)
- Figure 25-1: Egypt IVD Market by Segment, Estimated 2025-2030 (US$ million)
Chapter Twenty-Six: Romania
Romania IVD Market Overview
- Table 26-1: Romania IVD Market by Segment, Estimated 2025-2030 (US$ million)
- Figure 26-1: Romania IVD Market by Segment, Estimated 2025-2030 (US$ million)
News
Chapter Twenty-Seven: South Africa
South Africa IVD Market Overview
- Table 27-1: South Africa IVD Market by Segment, Estimated 2025-2030 (US$ million)
- Figure 27-1: South Africa IVD Market by Segment, Estimated 2025-2030 (US$ million)
Chapter Twenty-Eight: Indonesia
Indonesia IVD Market Overview
- Table 28-1: Indonesia IVD Market by Segment, Estimated 2025-2030 (US$ million)
- Figure 28-1: Indonesia IVD Market by Segment, Estimated 2025-2030 (US$ million)
Chapter Twenty-Nine: Chile
Chile IVD Market Overview
- Table 29-1: Chile IVD Market by Segment, Estimated 2025-2030 (US$ million)
- Figure 29-1: Chile IVD Market by Segment, Estimated 2025-2030 (US$ million)
News
Chapter Thirty: United Arab Emirates
United Arab Emirates IVD Overview
- Table 30-1: United Arab Emirates IVD Market by Segment, Estimated 2025-2030 (US$ million)
- Figure 30-1: United Arab Emirates IVD Market by Segment, Estimated 2025-2030 (US$ million)
News
Chapter Thirty-One: Vietnam
Vietnam IVD Market Overview
- Table 31-1: Vietnam IVD Market by Segment, Estimated 2025-2030 (US$ million)
- Figure 31-1: Vietnam IVD Market by Segment, Estimated 2025-2030 (US$ million)
News
Appendix: IVD Segment Revenues by Top 30 Countries, 2025–2030
Appendix Overview
Blood Bank Screening – Immunos
- Table A1: Blood Bank Screening – Immunos Revenue, by Top 30 Countries, Estimated 2025-2030 (US$ million)
General Chemistries and Critical Care
- Table A2: General Chemistries and Critical Care Revenue, by Top 30 Countries, Estimated 2025-2030 (US$ million)
Hematology and Coagulation
- Table A3: Hematology and Coagulation, by Top 30 Countries, Estimated 2025-2030 (US$ million)
Histology
- Table A4: Histology, by Top 30 Countries, Estimated 2025-2030 (US$ million)
Immunoassays – Microbiology
- Table A5: Immunoassays – Microbiology Revenue, by Top 30 Countries, Estimated 2025-2030 (US$ million)
Immunoassays – Non-Microbiology
- Table A6: Immunoassays – Non-Microbiology Revenue, by Top 30 Countries, Estimated 2025-2030 (US$ million)
Microbiology – ID-AST
- Table A7: Microbiology – ID-AST Revenue, by Top 30 Countries, Estimated 2025-2030 (US$ million)
Molecular Bloodstream-HAI
- Table A8: Molecular Bloodstream-HAI Revenue, by Top 30 Countries, Estimated 2025-2030 (US$ million)
Molecular HIV and Hepatitis
- Table A9: Molecular HIV and Hepatitis Revenue, by Top 30 Countries, Estimated 2025-2030 (US$ million)
Molecular Respiratory
- Table A10: Molecular Respiratory Revenue, by Top 30 Countries, Estimated 2025-2030 (US$ million)
Molecular – Other
- Table A11: Molecular – Other Revenue, by Top 30 Countries, Estimated 2025-2030 (US$ million)
Point-of-Care (POC) Critical Care
- Table A12: POC Critical Care Revenue, by Top 30 Countries, Estimated 2025-2030 (US$ million)
Point-of-Care (POC) Fecal Occult
- Table A13: POC Fecal Occult Revenue, by Top 30 Countries, Estimated 2025-2030 (US$ million)
Point-of-Care (POC) Glucose (All)
- Table A14: POC Glucose (All) Revenue, by Top 30 Countries, Estimated 2025-2030 (US$ million)
Point-of-Care (POC) Infectious Disease
- Table A15: POC Infectious Disease Revenue, by Top 30 Countries, Estimated 2025-2030 (US$ million)
Point-of-Care (POC) Pregnancy and Fertility
- Table A16: POC Pregnancy and Fertility Revenue, by Top 30 Countries, Estimated 2025-2030 (US$ million)
Other IVD
- Table A17: Other IVD Revenue, by Top 30 Countries, Estimated 2025-2030 (US$ million)
Other Point-of-Care (POC)
- Table A18: Other Point-of-Care Revenue, by Top 30 Countries, Estimated 2025-2030 (US$ million)
Related products
The Worldwide Market for IVD Tests, 19th Edition
May 21, 2026
The global in vitro diagnostics (IVD) market is entering a period of measured but positive growth, shaped less by disruptive platform launches and more by strategic portfolio realignment, digital integration, and selective innovation. Kalorama Information’s 19th Edition of The Worldwide Market for In Vitro Diagnostic (IVD) Tests examines how industry participants are navigating competitive pressures, cost constraints,…
Price range: $12,250.00 through $17,500.00
In Vitro Diagnostics (IVD) in the United States, 6th Edition
December 8, 2025
In Vitro Diagnostics (IVD) in the United States, 6th Edition provides a comprehensive analysis of the largest and most influential IVD market in the world. This report is an essential resource for companies, manufacturers, executives, marketers, and other key stakeholders seeking actionable insights into the U.S. IVD industry—a market that serves as a global incubator…
Price range: $5,600.00 through $8,000.00
30-Country In Vitro Diagnostic (IVD) Market Atlas [October 2023 Update]
October 27, 2023
The in vitro diagnostics (IVD) market is a global multi-billion-dollar industry, with significant revenue generated outside the United States. To facilitate successful business planning, it’s crucial to assess regional and country-level IVD markets. Kalorama’s 30 Country IVD Market Atlas report offers detailed insights into international markets, aiding in forecast modeling and strategic planning.
Key…
Price range: $5,000.00 through $7,500.00
